---
figid: PMC3248184__oncotarget-02-401-g001
figtitle: 'YB-1 drives preneoplastic progression: Insight into opportunities for cancer
  prevention'
organisms:
- Homo sapiens
- Mus musculus
- clinical samples
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC3248184
filename: oncotarget-02-401-g001.jpg
figlink: /pmc/articles/PMC3248184/figure/F1/
number: F1
caption: Using the Kinexus Kinex antibody microarray, we uncovered an enhancement
  in signal transduction along the MAPK/RSK pathway following YB-1 induction in HMECs.
  Activation of HER2 led to phosphorylation of MEK and, in turn, RSK. Downstream RSK
  substrates with a role in cell survival and proliferation demonstrated altered expression
  and activity. Select therapeutic agents that could inhibit signaling at each level
  of the MAPK/RSK cascade were identified. The specific phosphorylation sites and
  the percent change in protein expression following a 72-hour YB-1 induction in HMECs
  (%CFC) are provided in the table.
papertitle: 'YB-1 drives preneoplastic progression: Insight into opportunities for
  cancer prevention.'
reftext: Alastair H. Davies, et al. Oncotarget. 2011 May;2(5):401-406.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9481578
figid_alias: PMC3248184__F1
figtype: Figure
redirect_from: /figures/PMC3248184__F1
ndex: c8b37a95-dedf-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3248184__oncotarget-02-401-g001.html
  '@type': Dataset
  description: Using the Kinexus Kinex antibody microarray, we uncovered an enhancement
    in signal transduction along the MAPK/RSK pathway following YB-1 induction in
    HMECs. Activation of HER2 led to phosphorylation of MEK and, in turn, RSK. Downstream
    RSK substrates with a role in cell survival and proliferation demonstrated altered
    expression and activity. Select therapeutic agents that could inhibit signaling
    at each level of the MAPK/RSK cascade were identified. The specific phosphorylation
    sites and the percent change in protein expression following a 72-hour YB-1 induction
    in HMECs (%CFC) are provided in the table.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ERBB2
  - SRC
  - FGR
  - FYN
  - YES1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - PDK1
  - PDPK1
  - GSK3B
  - NFKBIA
  - NFKBIB
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - Erbb2
  - Src
  - Mdk
  - Rps6ka1
  - Pdk1
  - Pdpk1
  - Gsk3b
  - Nfkbib
  - Creb1
  - her2
  - src
  - pdk1
  - gsk3ba
  - nfkbiab
  - OSU-03012
  - chloride
  - Kaempferol
---
